Filing Flows › Conmed (CNMD) › Q2 2026 › vs Q2 2025
Conmed (CNMD) Q2 2026 vs Q2 2025 (year over year)
Conmed's revenue rose $1.1M (+0.3%) from $342M in Q2 2025 to $343M in Q2 2026. The biggest changes: Orthopedic Surgery +$11.6M (+8%); General Surgery −$10.4M (-5%). Gross margin 57.5% against 55.0% (+2.5 pts).
Conmed, Q2 2026: revenue $343M (+0.3% year over year), operating margin 10.6%, net earnings $23.1M, operating cash flow $37.1M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 57.5% | 55.0% | +2.5 pts |
| Operating margin | 10.6% | 11.1% | -0.5 pts |
| Net margin | 6.7% | 6.3% | +0.5 pts |
| Free cash flow margin | 9.9% | 6.8% | +3.1 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| General Surgery | $191M | $202M | −$10.4M | -5% |
| Orthopedic Surgery | $152M | $141M | $11.6M | +8% |
| Revenue | $343M | $342M | $1.1M | +0.3% |
| Gross profit | $197M | $188M | $9.1M | +5% |
| Cost of revenue | $146M | $154M | −$8.0M | -5% |
| Operating profit | $36.4M | $38.2M | −$1.8M | -5% |
| Operating expenses | $161M | $150M | $10.9M | +7% |
| Pre-tax earnings | $31.3M | $29.9M | $1.4M | +5% |
| Other expense, net | $5.1M | $8.2M | −$3.2M | -39% |
| Research & development | $15.5M | $14.1M | $1.4M | +10% |
| SG&A | $146M | $136M | $9.5M | +7% |
| Net earnings | $23.1M | $21.4M | $1.6M | +8% |
| Income tax | $8.3M | $8.5M | −$222K | -3% |
| Depreciation & amortization | $12.8M | $13.2M | −$387K | -3% |
| Share-based compensation | $5.2M | $4.9M | $327K | +7% |
| Working capital & other | $4.0M | $10.4M | −$6.4M | -62% |
| Operating cash flow | $37.1M | $29.1M | $8.0M | +27% |
| Free cash flow (OCF − capex) | $34.2M | $23.4M | $10.8M | +46% |
| Capital expenditures | $2.9M | $5.7M | −$2.8M | -49% |
Questions
How much did Conmed's revenue grow year over year in Q2 2026?
Conmed's revenue rose $1.1M (+0.3%) from $342M in Q2 2025 to $343M in Q2 2026.
What drove Conmed's revenue change in Q2 2026?
Orthopedic Surgery +$11.6M (+8%); General Surgery −$10.4M (-5%).